Supplemental Material for The Effects of Inhaled Flavors on Intravenous Nicotine

Keyword(s):  



2009 ◽  
Vol 207 (1) ◽  
pp. 153-162 ◽  
Author(s):  
Mehmet Sofuoglu ◽  
Aryeh I. Herman ◽  
Marc Mooney ◽  
Andrew J. Waters


1993 ◽  
Vol 264 (4) ◽  
pp. H1087-H1092
Author(s):  
F. W. Leung

The hypothesis that intravenous nicotine modulates gastric spinal afferent nerve function by its ganglionic-blocking property is tested. Stimulation of the gastric spinal afferent nerves in anesthetized rats is accomplished by intragastric capsaicin irrigation. Gastric blood flow is monitored by laser-Doppler flowmetry. The increase in gastric blood flow during intragastric capsaicin irrigation is significantly reduced by 4 and 40 micrograms.kg-1.min-1 of intravenous nicotine. The inhibition appears to be specific for the spinal afferent nerves as the increase in gastric blood flow induced by electrical stimulation of the vagal afferent nerves is unaltered by these doses of intravenous nicotine. A ganglionic-blocking dose (10 mg/kg) of intraperitoneal hexamethonium also significantly attenuates the gastric vasodilatory effect of intragastric capsaicin. Intravenous nicotine (40 micrograms.kg-1.min-1) combined with intraperitoneal hexamethonium (10 mg/kg) completely abolishes the gastric vasodilatory effect of intragastric capsaicin. These data suggest that intravenous nicotine offers a specific inhibition of the gastric spinal afferent nerve-mediated hyperemia, possibly as a consequence of its ganglionic-blocking property.



2018 ◽  
Vol 32 (9) ◽  
pp. 986-994 ◽  
Author(s):  
Gerald W Valentine ◽  
Elise E DeVito ◽  
Peter I Jatlow ◽  
Ralitza Gueorguieva ◽  
Mehmet Sofuoglu

Objective: This double-blind, placebo controlled study examined whether menthol inhaled from an electronic cigarette (e-cigarette) would change subjective and withdrawal alleviating effects of intravenous nicotine in young adult smokers. Methods: A total of 32 menthol-preferring smokers and 25 non-menthol-preferring smokers participated in the study that consisted of a random sequence of three different inhaled menthol conditions (0.0%, 0.5%, and 3.2%) across three test sessions (a single menthol condition per session). In each test session (performed at least 24 hours apart), a random order of saline, and two different nicotine infusions of 0.25 mg and 0.5 mg/70 kg of bodyweight were administered, one hour apart, concurrent with menthol inhalation. Results: While menthol did not alter the positive subjective effects of nicotine, menthol significantly enhanced aversive effects of nicotine in non-menthol-preferring smokers and reduced smoking urges in menthol-preferring smokers. In addition, menthol-preferring smokers reported blunted positive subjective responses to nicotine and less severe nicotine withdrawal after overnight nicotine deprivation. Finally, compared to non-menthol-preferring smokers, menthol-preferring smokers had a significantly lower baseline nicotine metabolite ratio indicating slower nicotine metabolism within our sample of menthol-preferring smokers. Conclusions: Our findings did not support an enhancement of nicotine’s positive subjective effects from inhaled menthol. However, as compared to non-menthol-preferring smokers, menthol-preferring smokers had blunted positive subjective responses to nicotine and reduced overnight withdrawal severity that may be partly due to inhibition of nicotine metabolism from chronic exposure to inhaled menthol. Collectively, these results reveal a more complex and nuanced role of inhaled menthol in smokers than previously recognized.



2002 ◽  
Vol 303 (2) ◽  
pp. 664-672 ◽  
Author(s):  
Anthony S. Rauhut ◽  
Stephanie N. Mullins ◽  
Linda P. Dwoskin ◽  
Michael T. Bardo


2008 ◽  
Vol 33 (8) ◽  
pp. 2042-2043 ◽  
Author(s):  
Heather G Fulton ◽  
Sean P Barrett


2013 ◽  
Vol 39 (6) ◽  
pp. 1431-1440 ◽  
Author(s):  
Elise E DeVito ◽  
Aryeh I Herman ◽  
Andrew J Waters ◽  
Gerald W Valentine ◽  
Mehmet Sofuoglu


Sign in / Sign up

Export Citation Format

Share Document